Navigation Links
CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
Date:8/19/2007

apy, the immune system is severely weakened and is less able to mount an effective anti-tumor immune response. Other immunotherapies are administered later in cancer therapy, which can limit their effectiveness.

CEL-SCI Corporation is developing new immune system based treatments for cancer and infectious diseases. The Company has operations in Vienna, Virginia and Baltimore, Maryland. The Company's lead product Multikine is cleared to enter a global Phase III clinical trial in advanced primary head and neck cancer patients in the U.S. and Canada. CEL-SCI's other products, which are currently in pre-clinical stage, have shown protection against a number of diseases in animal tests and are being tested against diseases associated with bio-defense and avian flu.

When used in this report, the words "intends," "believes," "anticipated" and "expects" and similar expressions are intended to identify forward-looking statements. Such statements are subject to risks and uncertainties which could cause actual results to differ materially from those projected. Factors that could cause or contribute to such differences include, an inability to duplicate the clinical results demonstrated in clinical studies, timely development of any potential products that can be shown to be safe and effective, receiving necessary regulatory approvals, difficulties in manufacturing any of the Company's potential products, inability to raise the necessary capital and the risk factors set forth from time to time in CEL-SCI Corporation's SEC filings, including but not limited to its report on Form 10- K for the year ended September 30, 2006. The Company undertakes no obligation to publicly release the result of any revision to these forward-looking statements which may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE CEL-SCI Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
2. CEL-SCI Presents Long-Term Cancer Survival Data With Multikine
3. CEL-SCIs Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals
4. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
5. Vastox Awarded £400,000 Grant to Support R&D at Carbohydrate Chemistry Facility
6. FDA Re-Inspection Results in Positive Re-Classification of Guayama Facility
7. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
8. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
9. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Calif. , July 28, 2015   Regulus ... company leading the discovery and development of innovative medicines ... results and highlights for the quarter ended June 30, ... financial markets close. Regulus will host ... 2015, at 5:00 pm Eastern Daylight Time to discuss ...
(Date:7/28/2015)... ST. LOUIS, July 28, 2015  Express Scripts Holding ... net income attributable to Express Scripts stockholders of $600.1 ... diluted share, as detailed in Table 4, were $1.44 ... "It is clear many companies across healthcare are validating ... Chairman and Chief Executive Officer. "But, what matters most ...
(Date:7/28/2015)... PALO ALTO, Calif. , July 28, 2015 /PRNewswire/ ... International Holding Corp., the parent company of CPI International, ... the third quarter ended July 3, 2015 with the ... release regarding its results for the quarter.  At 11 ... hold a telephonic conference call in conjunction with this ...
Breaking Medicine Technology:Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 13Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 14Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 15Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 16Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 17Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 18Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 19Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 20Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 21Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 22Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 23Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 24Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 25CPI International To Announce Third Quarter 2015 Financial Results 2
... company Novalung GmbH continue to gain acceptance.  Additional financing will allow the Talheim ( Germany ) based company to accelerate the development of new products. , ... , ... ... ...
... March 23 LensAR, Inc., a leading developer ... other ocular applications, today announced the appointment of Michael ... sales and marketing and Ron Goldrich as ... O,Rourke and Mr. Goldrich, who both possess extensive product ...
Cached Medicine Technology:Novalung Records 50% Growth 2Novalung Records 50% Growth 3LensAR Advances Commercialization Efforts With Appointment of Key Sales and Marketing Executives 2LensAR Advances Commercialization Efforts With Appointment of Key Sales and Marketing Executives 3LensAR Advances Commercialization Efforts With Appointment of Key Sales and Marketing Executives 4
(Date:7/28/2015)... ... July 28, 2015 , ... The Triumph Modular, ... practices, consumer education, resource library, floor plans, educational blog and wide use of ... offers regular posts with valuable links to useful reports by industry experts. Comments ...
(Date:7/28/2015)... ... 28, 2015 , ... Darryl Worley’s Annual Tennessee River Run ... year of raising money for the Darryl Worley Foundation. Worley will host Wade ... concert Saturday, Oct. 3. , This year’s concert will have a second stage ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... United States with 1 in 68 children currently affected with the disorder. For ... child on the road to recovery is extremely daunting. That’s where Talk About ...
(Date:7/28/2015)... ... July 28, 2015 , ... ADLINK Technology, ... for edge devices that enable the Internet of Things (IoT), announced its new ... processor to provide exceptional computing power and multitasking capabilities. The MLC 4-21 is ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... much-anticipated U.S. commercial launch of its ORTHALIGN PLUS® system, a palm-sized, single-use navigation ... , “OrthAlign successfully combined precision with practicality in a revolutionary way for ...
Breaking Medicine News(10 mins):Health News:Triumph Modular Launches Refreshed Modular Building Industry Website 2Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 2Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 3Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3
... CHICAGODespite grim prognoses and aggressive treatments, cancer patients suffering ... rate their quality of life more optimistically than their ... School of Medicine study. The research ... up if there is something more to be said, ...
... ... Testifies on Effects of These Head Injuries on Developing Brains , ... Washington, DC (Vocus) May 20, ... Health, Education, Labor, and Pensions Committee of the United States House of Representatives today ...
... ... of Life for Patients, , ... Arlington Heights, IL (Vocus) May 20, 2010 -- Advocating the need for a medical Team ... Surgeons (ASPS), in partnership with the American Society of Breast Surgeons (ASBS), ...
... ,Spare tire, had strongest association with senility, study found ... study suggests that excess fat in the abdomen during ... life. , An estimated 24.3 million people worldwide suffer ... other causes. , In the new study, Dr. Sudha ...
... ... is pleased to announce the hire of Ms. Linda Spooner as Director of Project ... (PRWEB) ... Ms. Linda Spooner as Director of Project Management., , ,Ms. Spooner brings over 10 ...
... defibrillators add more than $4 billion to U.S. health ... -- Costs for patients with chronic heart failure and ... are turning to pricey, surgically implanted devices such as ... , Researchers led by Dr. Peter Groeneveld of Philadelphia ...
Cached Medicine News:Health News:Caregivers of brain cancer patients play a key role 2Health News:Academic Impacts of Concussions for Students at Issue in House of Representatives 2Health News:Academic Impacts of Concussions for Students at Issue in House of Representatives 3Health News:Plastic Surgeons, Breast Surgeons Urge Team Approach to Breast Cancer Care, 2Health News:Plastic Surgeons, Breast Surgeons Urge Team Approach to Breast Cancer Care, 3Health News:Plastic Surgeons, Breast Surgeons Urge Team Approach to Breast Cancer Care, 4Health News:Rapport International Hires Linda Spooner to Lead Project Management 2
Gamma Glutamyl Transferase reagent is used for the quantitative determination of Gamma -GT in human serum....
For the quantitative kinetic determination of amylase activity, using manual or automated procedures, in human serum and urine....
For quantitative determination of amylase in human serum....
g-GT Liquid Reagent (Kinetic Method). Wavelength: 405 nm. Linear range: 0-200 U/mL. Prepare Working Reagent in the ratio of 5 parts R1 to 1 part of R2, (i.e., 50 mL R1 and 10 mL R2)....
Medicine Products: